Percutaneous Alginate Hydrogel Endomyocardial Injection with a Novel Dedicated Catheter Delivery System: An Animal Feasibility Study
Journal of Cardiovascular Translational Research · 2024
DOI: 10.1007/s12265-024-10497-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Translational Research, 2024. Verfasst von Bo Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Alginates, Feasibility Studies, Cardiac Catheters, Cardiac Catheterization. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deke Medical.
Abstract (Originalsprache)
The objective of this preclinical study was to evaluate the feasibility and safety of transcatheter endocardial alginate hydrogel injection (TEAi) in a large animal model, utilizing the high-stiffness XDROP® alginate hydrogel in combination with the dedicated EndoWings® catheter-based system. All swine ( n = 9) successfully underwent TEAi without complications. Acute results from a subset of animals ( n = 5) demonstrated the ability of the catheter to access a wide range of endomyocardial areas and achieve consecutive circumferential hydrogel distribution patterns within the mid-left ventricular wall. Histological examinations at 6 months ( n = 4) demonstrated that the XDROP® remained localized within the cardiac tissue. In addition, serial echocardiographic imaging showed that XDROP® had no adverse impacts on LV systolic and diastolic functions. In conclusion, this innovative combination technology has the potential to overcome the translational barriers related to alginate hydrogel delivery to the myocardium. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
- Corrib Research Centre for Advanced Imaging and Core Laboratory, University of Galway, Galway, Ireland.
- Department of Medicine, Division of Cardiovascular Medicine, University of Virginia, Charlottesville, VA, USA.
- National Engineering Research Center for Biomaterials, Sichuan University, Sichuan, China.
- Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Corrib Research Centre for Advanced Imaging and Core Laboratory, University of Galway, Galway, Ireland. patrick.serruys@universityofgalway.ie.
ORCID-Profile: Ling Tao
Förderung
- Deke Medical
Zitieren
APA
Wang, B., Gao, C., Lim, S., Wang, R., Zhu, C. J., Onuma, Y., Wang, Y., Gao, R., Serruys, P. W. J. C., Lee, R. J., & Tao, L. (2024). Percutaneous Alginate Hydrogel Endomyocardial Injection with a Novel Dedicated Catheter Delivery System: An Animal Feasibility Study. Journal of Cardiovascular Translational Research. https://doi.org/10.1007/s12265-024-10497-8
Vancouver
Wang B, Gao C, Lim S, Wang R, Zhu CJ, Onuma Y, et al. Percutaneous Alginate Hydrogel Endomyocardial Injection with a Novel Dedicated Catheter Delivery System: An Animal Feasibility Study. Journal of Cardiovascular Translational Research. 2024. doi:10.1007/s12265-024-10497-8
BibTeX
@article{Wang2024,
author = {Wang, Bo and Gao, Chao and Lim, Scott and Wang, Rutao and Zhu, Cun-Jun and Onuma, Yoshinobu and Wang, Yunbing and Gao, Runlin and Serruys, Patrick W J C and Lee, Randall J and Tao, Ling},
title = {Percutaneous Alginate Hydrogel Endomyocardial Injection with a Novel Dedicated Catheter Delivery System: An Animal Feasibility Study},
journal = {Journal of Cardiovascular Translational Research},
year = {2024},
doi = {10.1007/s12265-024-10497-8}
}
EUVIMED